Abstract DP158: Cost-effectiveness of theoretical benefit of PCSK9 inhibitor use in patients with stroke due to severe intracranial atherosclerosis: A post hoc analysis of the SAMMPRIS trial
Year: 2026
Type: conference-abstract
Source: Stroke
Authors: Caroline Kellogg, Elena Badillo Goicoechea, David Kim, Shadi Yaghi, Seemant Chaturvedi, Rachel Mehendale, Karen Orjuela, Tareq Kass-Hout, Rami Morsi, Jacqueline Morales, Eesha Singh, Shyam Prabhakaran, Matthew Smith, James Brorson, Samiksha Golani, Sofia Mazuera, Carolyn Zhao, Rachael Kang, Jessica Pillajo, James Siegler
Institutions: University of Chicago, Lifespan, University of Maryland, Baltimore
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7126040576
Cites:
Cited by:
Related to: